PPA
GBIO

Parametric Portfolio Associates’s Generation Bio GBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$128K Buy
1,745
+717
+70% +$41.5K ﹤0.01% 3524
2021
Q4 		$73K Sell
1,028
-170
-14% -$29.7K ﹤0.01% 3581
2021
Q3 		$300K Sell
1,198
-78
-6% -$18.7K ﹤0.01% 3306
2021
Q2 		$343K Buy
1,276
+239
+23% +$71.5K ﹤0.01% 3227
2021
Q1 		$295K Buy
+1,037
New +$332K ﹤0.01% 3723

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return